Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy

C E Mogensen
PMCID: PMC1499854  PMID: 6809187

Abstract

Six men aged 26-35 years with proteinuria due to insulindependent juvenile-onset diabetes were treated for moderate hypertension (mean blood pressure 162/103 mm Hg) and studied for a mean of 73 months for the effect on the progression of nephropathy. All patients were of normal weight. During a mean control period of 28 months before treatment the mean glomerular filtration rate (three or four measurements) was 86·1 ml/min and mean 24-hour urinary albumin excretion (also three or four measurements) 3·9 g (range 0·5-8·8 g).

During antihypertensive treatment the mean systolic blood pressure fell to 144 mm Hg and mean diastolic pressure to 95 mm Hg. In the control period five patients had shown a mean monthly decline in glomerular filtration rate of 1·23 ml/min; with antihypertensive treatment, however, this decline fell to 0·49 ml/min (2p=0·042). In the remaining patient the glomerular filtration rate was 137 ml/min before treatment and 135 ml/min at the end of the treatment period. In all patients the mean yearly increase in albumin clearance (expressed as a percentage of the glomerular filtration rate) fell from 107% before treatment to 5% during treatment (2p=0·0099).

This small study indicates that antihypertensive treatment slows the decline in renal function in diabetic nephropathy. Clinical trials beginning treatment in the incipient phase of diabetic nephropathy will define the optimal modality of treatment in this large patient population.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Day J. L. The metabolic consequences of adrenergic blockade: a reveiw. Metabolism. 1975 Aug;24(8):987–996. doi: 10.1016/0026-0495(75)90090-6. [DOI] [PubMed] [Google Scholar]
  2. Deckert T., Poulsen J. E. Diabetic nephropathy: fault or destiny? Diabetologia. 1981 Sep;21(3):178–183. doi: 10.1007/BF00252651. [DOI] [PubMed] [Google Scholar]
  3. Gibson D. G. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs. 1974;7(1):8–38. doi: 10.2165/00003495-197407010-00002. [DOI] [PubMed] [Google Scholar]
  4. Hostetter T. H., Rennke H. G., Brenner B. M. Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kidney Dis. 1982 Mar;1(5):310–314. doi: 10.1016/s0272-6386(82)80032-2. [DOI] [PubMed] [Google Scholar]
  5. Hostetter T. H., Rennke H. G., Brenner B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med. 1982 Mar;72(3):375–380. doi: 10.1016/0002-9343(82)90490-9. [DOI] [PubMed] [Google Scholar]
  6. Jones R. H., Hayakawa H., Mackay J. D., Parsons V., Watkins P. J. Progression of diabetic nephropathy. Lancet. 1979 May 26;1(8126):1105–1106. doi: 10.1016/s0140-6736(79)91788-4. [DOI] [PubMed] [Google Scholar]
  7. Keen H., Track N. S., Sowry G. S. Arterial pressure in clinically apparent diabetics. Diabete Metab. 1975 Sep;1(3):159–178. [PubMed] [Google Scholar]
  8. Keen H., Viberti G. C. Genesis and evolution of diabetic nephropathy. J Clin Pathol. 1981 Nov;34(11):1261–1266. doi: 10.1136/jcp.34.11.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kølendorf K., Bonnevie-Nielsen V., Broch-Møller B. A trial of metoprolol in hypertensive insulin-dependent diabetic patients. Acta Med Scand. 1982 May;211(3):175–178. doi: 10.1111/j.0954-6820.1982.tb01923.x. [DOI] [PubMed] [Google Scholar]
  10. Miles D. W., Mogensen C. E., Gundersen H. J. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest. 1970 Aug;26(1):5–11. doi: 10.3109/00365517009049206. [DOI] [PubMed] [Google Scholar]
  11. Mogensen C. E. Glomerular filtration rate and renal plasma flow in long-term juvenile diabetics without proteinuria. Br Med J. 1972 Nov 4;4(5835):257–259. doi: 10.1136/bmj.4.5835.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mogensen C. E. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest. 1971 Sep;28(1):91–100. doi: 10.3109/00365517109090667. [DOI] [PubMed] [Google Scholar]
  13. Mogensen C. E. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest. 1976 Jul;36(4):383–388. doi: 10.1080/00365517609055274. [DOI] [PubMed] [Google Scholar]
  14. Oakley W. G., Pyke D. A., Tattersall R. B., Watkins P. J. Long-term diabetes. A clinical study of 92 patients after 40 years. Q J Med. 1974 Jan;43(169):145–156. [PubMed] [Google Scholar]
  15. Parving H. H., Mogensen C. E., Jensen H. A., Evrin P. E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet. 1974 Jun 15;1(7868):1190–1192. doi: 10.1016/s0140-6736(74)91002-2. [DOI] [PubMed] [Google Scholar]
  16. Pedersen E. B., Mogensen C. E. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest. 1976 May;36(3):231–237. [PubMed] [Google Scholar]
  17. Pedersen E. B., Mogensen C. E., Larsen J. S. Effects of exercise on urinary excretion of albumin and beta 2-microglobulin in young patients with mild essential hypertension without treatment and during long-term propranolol treatment. Scand J Clin Lab Invest. 1981 Sep;41(5):493–498. doi: 10.3109/00365518109090488. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES